Abstract
To determine factors that may modify the association between hormone therapy (HT) and breast cancer risk. Prospective cohort study (the Melbourne Collaborative Cohort Study) of 24,479 women aged 40 to 69 years. History of HT use was collected at baseline and 4 years later by questionnaire. By June 2002, 336 cases of breast cancer were diagnosed among 13,444 women postmenopausal at baseline. Association of breast cancer risk with history of HT use was analyzed using proportional hazards models. The hazard ratio (HR) for recent HT use (current or stopped within the last year) was elevated (HR 1.51; 95% CI, 1.16-1.98) but was not significantly increased for past HT users (HR 1.19; 95% CI, 0.86-1.64). Recent HT use was associated with better differentiated tumors but was not more likely to be associated with estrogen receptor-positive / progesterone receptor-positive tumors. There was little evidence of interactions between recent HT use and body mass index, alcohol intake, parity, and smoking, although the HR for recent HT use in categories of alcohol consumption was greatest in women consuming the most alcohol (HR 2.37; 95% CI, 1.45-3.88 for those consuming > or = 10 g/d versus HR 1.33; 95% CI, 0.85-2.08 for nondrinkers, P intera...Continue Reading
References
Nov 15, 1992·American Journal of Epidemiology·S M GapsturA R Folsom
Sep 6, 1995·Journal of the National Cancer Institute·S E HankinsonF E Speizer
Nov 1, 1994·Cancer Causes & Control : CCC·C SchairerR N Hoover
Jul 1, 1994·Cancer·N A Wynstra
Feb 28, 1998·JAMA : the Journal of the American Medical Association·S A Smith-WarnerD J Hunter
Feb 26, 1999·Journal of the National Cancer Institute·C SchairerR N Hoover
Mar 10, 1999·Journal of Clinical Pathology·I F O'ConnorS Shousha
Apr 21, 1999·International Journal of Cancer. Journal International Du Cancer·C MagnussonI Persson
Jul 29, 1999·British Journal of Cancer·H JernströmH Olsson
Feb 16, 2000·Lancet·A M KavanaghG G Giles
Jul 10, 2001·Cancer·M PompiliG Gasbarrini
May 15, 2002·Fertility and Sterility·Evan R Simpson
Jul 19, 2002·JAMA : the Journal of the American Medical Association·Jacques E RossouwUNKNOWN Writing Group for the Women's Health Initiative Investigators
Jul 23, 2002·Journal of Medical Screening·J EstèveL Remontet
Nov 8, 2002·Cancer Causes & Control : CCC·Libby M MorimotoAnne McTiernan
Nov 19, 2002·Annals of Internal Medicine·Wendy Y ChenFrank E Speizer
Oct 8, 2003·Annals of Internal Medicine·Silvano GallusCarlo La Vecchia
Feb 20, 2004·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Heather Spencer FeigelsonEugenia E Calle
Apr 15, 2004·JAMA : the Journal of the American Medical Association·Garnet L AndersonUNKNOWN Women's Health Initiative Steering Committee
Citations
Jan 1, 2014·Epidemiologic Reviews·Mark F MunsellAmy Trentham-Dietz
Apr 29, 2006·Menopause : the Journal of the North American Menopause Society·Andrew M Kaunitz
Jan 2, 2007·Advances in Anatomic Pathology·I-Tien Yeh
Nov 26, 2015·International Journal of Cancer. Journal International Du Cancer·Usha SalagameKaren Canfell
Jan 10, 2012·Maturitas·Melinda ProtaniJennifer Muller
Oct 7, 2015·Australian and New Zealand Journal of Public Health·Susan J JordanPenelope M Webb
Jun 25, 2015·PloS One·Winnifred CutlerKari Hart
May 28, 2013·Asia-Pacific Journal of Public Health·Thunyarat AnothaisintaweeAmmarin Thakkinstian
Nov 8, 2018·PloS One·Usha SalagameKaren Canfell
Aug 8, 2018·European Journal of Epidemiology·Marie Søfteland SandveiSigne Opdahl
Sep 11, 2020·PloS One·Winnifred CutlerHugo M Montesinos-Yufa
Jun 11, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Hazel B NicholsAnthony J Swerdlow